From Concept to Commercialization: Navigating Multimodal Strategy & Early IVD Migration

Join Roche for an interactive workshop session featuring rapid technology demonstrations, live polling, table-based breakouts, candid networking and fireside chats.

• Part 1: The Oncology Story – From Discovery to Standard of Care: This segment focuses on digital pathology, computational pathology, and multiplexing. We will highlight the strategic value of moving the IVD development process earlier into the drug timeline and include an interactive session for attendees to map regulatory and operational hurdles.  
• Part 2: Beyond Tissue – Non-Oncology & Multimodality: This section explores precision medicine in immunology and neurology, examining how multi-omic data is reshaping clinical trials and how to manage multimodal complexity across a drug’s lifecycle.